KRAS mutations often occur simultaneously with tumor protein p53 in pancreatic ductal adenocarcinoma, Kelch-like ECH-associated protein 1 in non-small cell lung cancer, and PIK3CA mutation in colorectal cancer [31]. This evidence concerns the gene TP53 and colorectal cancer.